Chapter
The Challenges in Developing a Pipeline for Psychedelic Drug Use
58:20 - 1:13:32 (15:11)
Developing a pipeline for training therapists or facilitators to administer psychedelic drugs is extremely controversial due to differing opinions, and the lack thereof may cause a rise in dangerous gray and black market options for treatments. Additionally, there will be attributed suicides and accidents to the use of these drugs, making it important for the Adecayce Foundation and the Harvard Pulse Foundation to continue researching and developing policy focused on psychedelics.
Clips
Experts highlight the risks associated with unregulated microdosing of drugs and mention testing services available for identifying drugs in New Zealand and organizations like DanceSafe in the US that offer drug testing kits.
58:20 - 1:02:34 (04:14)
Summary
Experts highlight the risks associated with unregulated microdosing of drugs and mention testing services available for identifying drugs in New Zealand and organizations like DanceSafe in the US that offer drug testing kits.
ChapterThe Challenges in Developing a Pipeline for Psychedelic Drug Use
Episode#619: Dr. Suresh Muthukumaraswamy — LSD Microdosing, Classical Psychedelics vs. Ketamine, Science and Speed in New Zealand, Placebo Options, and The Infinite Possibilities of Studying Mind-Altering Compounds
PodcastThe Tim Ferriss Show
Developing a pipeline for training psychedelic therapy facilitators is one of the most challenging issues to face in the coming years, as it is necessary to tackle the controversiality surrounding it to prevent black-market charlatans, which pose their problems.
1:02:35 - 1:10:03 (07:28)
Summary
Developing a pipeline for training psychedelic therapy facilitators is one of the most challenging issues to face in the coming years, as it is necessary to tackle the controversiality surrounding it to prevent black-market charlatans, which pose their problems. A certification program is being developed that can be applied to psychiatric MD training for people who want to add this type of training and qualification to their existing track, which is likely to bring MDMA-assisted therapy down the pipeline first since it is the most advanced in treating PTSD.
ChapterThe Challenges in Developing a Pipeline for Psychedelic Drug Use
Episode#619: Dr. Suresh Muthukumaraswamy — LSD Microdosing, Classical Psychedelics vs. Ketamine, Science and Speed in New Zealand, Placebo Options, and The Infinite Possibilities of Studying Mind-Altering Compounds
PodcastThe Tim Ferriss Show
The potential risks of psychedelic use must be mitigated through careful regulation to prevent political backlash and tragedies, such as suicides and accidents, that could threaten the society’s ability to use these substances to treat mental health issues effectively.
1:10:03 - 1:13:32 (03:28)
Summary
The potential risks of psychedelic use must be mitigated through careful regulation to prevent political backlash and tragedies, such as suicides and accidents, that could threaten the society’s ability to use these substances to treat mental health issues effectively.